Aug 2026
Frequent mutations in the BIRC3 gene promote metastatic potential of nasopharyngeal carcinoma cells through the TRAF2-NF-κB pathway.
Findings suggest the therapeutic feasibility of targeting the BIRC3/TRAF2/NF-κB axis in the treatment of NPC and suggest that BIRC3 acts as a regulator of the malignant features of NPC cells.
Xue Liu, Yuping Liu, Bi-Yun Zhu et al.
· Cellular Signalling · 0 citations